The treatment of Cataracts & Multiple Sclerosis with vitamins

Cataracts and Multiple Sclerosis: Mitamins custom make quality formulas for the treatment of Cataracts & Multiple Sclerosis with vitamins. A Cataracts & Multiple Sclerosis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Multiple Sclerosis

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Riboflavin
    125
    mg
    7353%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Folate
    800
    mcg
    200%
    Vitamin B12
    550
    mcg
    9167%
    Biotin
    50
    mcg
    17%
    Pantothenic Acid
    50
    mg
    500%
    Zinc
    10
    mg
    67%
    Selenium
    200
    mcg
    286%
  • Amount Per Serving
    % DV
    Copper
    1
    mg
    50%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
    PABA
    50
    mg
    *
    Alpha Lipoic Acid
    50
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    N-Acetyl L-Cysteine
    500
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cataracts and Multiple Sclerosis
Serving Size:4-5

Cataracts and Multiple Sclerosis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Aclasta(R) Receives European Approval As First Once-yearly Treatment For Postmenopausal Osteoporosis
Aclasta® (zoledronic acid 5 mg) has gained European Union approval as the first and only once-yearly treatment for women with postmenopausal osteoporosis. The announcement closely follows the recent approval in the US, where the Food and Drug Administration (FDA) approved Aclasta under the brand name Reclast® in August 2007. The European Commission decision applies to all 27 member states, Norway and Iceland.
European College Of Neuropsychopharmacology Congress 2007
Achievements and future perspectives in neuropsychopharmacologyMental disorders are major causes of disability worldwide and rank as number one in terms of direct and indirect health economic costs as a recent ECNP commissioned report has demonstrated (Wittchen et al 2005). Depression, for instance, produces the greatest decrement in health compared with the common chronic diseases angina pectoris, arthritis, asthma, and diabetes (Moussavi et al.
This information concerning the support of Cataracts and Multiple Sclerosis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments